
Number of publications published per year by Benlloch, Salvador. (Source : PubMed)

Distribution of publications types for Benlloch, Salvador. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer.
Curr Opin Oncol
2010;22;2
Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain.
Clin Transl Oncol
2010;12;2
The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.
PLoS ONE
2010;5;3

Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.
Liver Transpl.
2009;15;12
Utility of p16 immunohistochemistry for the identification of Lynch syndrome.
Clin. Cancer Res.
2009;15;9

Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.
Ann. Oncol.
2009;20;1

Gastrointestinal complications in liver transplant recipients: MITOS study.
Transplant. Proc.
2007;39;7


[Candidate selection for liver transplantation]
Gastroenterol Hepatol
2007;30;1

Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors.
Eur J Gastroenterol Hepatol
2006;18;12


Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.
Hepatology
2006;44;5
[ See timeline ] [ See all publications ]
means that Benlloch, Salvador has 12 papers cited a least 12 times - methodology
HepatoGastroenterology Service, Hospital Universitari La Fe, Valencia, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.